IL4 and neoplasm: Additionally, CCL2 has been reported as potently attracting BMDSCs, such as TAMs, to the tumor site [178] and have the capacity to upregulate cathepsin expression based on their responsiveness to IL-4, -6 and -10 stimulation [98].